Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia

Leukemia volume 17, pages 1865–1870 (2003)Cite this article

Abstract

Allogeneic blood and marrow transplantation (BMT) is curative for many patients with high-risk and relapsed acute lymphoblastic leukemia (ALL). However, relapse is an important cause of post-transplantation failure, and there are no reliable markers to predict relapse. A retrospective review of patients with ALL who underwent matched related allogeneic BMT was carried out to examine whether the rate of lymphocyte recovery after transplantation had any prognostic value in ALL. The absolute lymphocyte count (ALC) at days 21 and 30 after transplantation was obtained for 43 patients who received transplants during an 18-year period. Patients with an ALC of 175 × 106/l or less on day 21 were more likely to relapse than those with ALC greater than 175 × 106/l (relative risk, 4; 95% confidence interval, 1.5–11.2). Patients with slower lymphocyte recovery had significantly lower relapse-free survival than those with faster recovery (P=0.0028). There was also a trend toward poorer overall survival among those with a slow lymphocyte recovery (log-rank test; P=0.028). The rate of lymphocyte recovery is prognostic in patients with ALL undergoing allogeneic BMT, and this should be integrated with other predictors to identify patients at high risk of relapse. Such patients could be considered for interventions aimed at prevention of relapse, including rapid withdrawal of immunosuppressive medication or donor lymphocyte infusion.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Cortes JE, Kantarjian HM . Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 1995; 76: 2393–2417.

    Article  CAS  PubMed  Google Scholar 

  2. Butturini A, Gale RP . Chemotherapy versus transplantation in acute leukaemia. Br J Haematol 1989; 72: 1–8.

    Article  CAS  PubMed  Google Scholar 

  3. Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K et al. Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 1991; 115: 13–18.

    Article  CAS  PubMed  Google Scholar 

  4. Sebban C, Lepage E, Vernant JP, Gluckman E, Attal M, Reiffers J et al for the French Group of Therapy of Adult Acute Lymphoblastic Leukemia. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. J Clin Oncol 1994; 12: 2580–2587.

    Article  CAS  PubMed  Google Scholar 

  5. Barrett AJ, Horowitz MM, Pollock BH, Zhang MJ, Bortin MM, Buchanan GR et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. N Engl J Med 1994; 331: 1253–1258.

    Article  CAS  PubMed  Google Scholar 

  6. De Witte T, Awwad B, Boezeman J, Schattenberg A, Muus P, Raemaekers J et al. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. Bone Marrow Transplant 1994; 14: 767–774.

    CAS  PubMed  Google Scholar 

  7. Saarinen UM, Mellander L, Nysom K, Ringden O, Schroeder H, Glomstein A et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO). Bone Marrow Transplant 1996; 17: 357–363.

    CAS  PubMed  Google Scholar 

  8. Dopfer R, Henze G, Bender-Gotze C, Ebell W, Ehninger G, Friedrich W et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 1991; 78: 2780–2784.

    CAS  PubMed  Google Scholar 

  9. Hoogerbrugge PM, Gerritsen EJ, vd Does-van den Berg A, vd Berg H, Zwinderman AH, Hermans J et al. Case-control analysis of allogeneic bone marrow transplantation versus maintenance chemotherapy for relapsed ALL in children. Bone Marrow Transplant 1995; 15: 255–259.

    CAS  PubMed  Google Scholar 

  10. Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P et al. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association. J Clin Oncol 1995; 13: 352–358.

    Article  CAS  PubMed  Google Scholar 

  11. Doney K, Fisher LD, Appelbaum FR, Buckner CD, Storb R, Singer J et al. Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991; 7: 453–459.

    CAS  PubMed  Google Scholar 

  12. Ringden O, Horowitz MM . Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry. Transplant Proc 1989; 21: 2989–2992.

    CAS  PubMed  Google Scholar 

  13. Powles R, Singhal S, Treleaven J, Kulkarni S, Horton C, Mehta J . Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation. Blood 1998; 91: 3481–3486.

    CAS  PubMed  Google Scholar 

  14. Kumar S, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ et al. Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia. Bone Marrow Transplant 2001; 28: 951–956.

    Article  CAS  PubMed  Google Scholar 

  15. Bostrom B, Woods WG, Nesbit ME, Krivit W, Kersey J, Weisdorf D et al. Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation. J Clin Oncol 1987; 5: 376–381.

    Article  CAS  PubMed  Google Scholar 

  16. Mehta J . The first clinical use of donor leukocyte infusions for the treatment of leukemia relapsing after allogeneic bone marrow transplantation. Blood 1996; 87: 4010.

    CAS  PubMed  Google Scholar 

  17. Singhal S, Powles R, Kulkarni S, Treleaven J, Saso R, Mehta J . Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse. Leukemia Lymphoma 1999; 32: 505–512.

    Article  CAS  PubMed  Google Scholar 

  18. Collins Jr RH, Shpilberg O, Drobyski WR, Porter DL, Giralt S, Champlin R et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433–444.

    Article  PubMed  Google Scholar 

  19. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al for the European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041–2050.

    CAS  PubMed  Google Scholar 

  20. Collins Jr RH, Goldstein S, Giralt S, Levine J, Porter D, Drobyski W et al. Donor leukocyte infusions in acute lymphocytic leukemia. Bone Marrow Transplant 2000; 26: 511–516.

    Article  PubMed  Google Scholar 

  21. Yazaki M, Andoh M, Ito T, Ohno T, Wada Y . Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion. Bone Marrow Transplant 1997; 19: 393–394.

    Article  CAS  PubMed  Google Scholar 

  22. Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999; 13: 2079–2086.

    Article  CAS  PubMed  Google Scholar 

  23. Pavletic ZS, Joshi SS, Pirruccello SJ, Tarantolo SR, Kollath J, Reed EC et al. Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies. Bone Marrow Transplant 1998; 21: 33–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N Engl J Med 1979; 300: 1068–1073.

    Article  CAS  PubMed  Google Scholar 

  25. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562.

    CAS  PubMed  Google Scholar 

  26. Weisdorf DJ, Nesbit ME, Ramsay NK, Woods WG, Goldman AI, Kim TH et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J Clin Oncol 1987; 5: 1348–1355.

    Article  CAS  PubMed  Google Scholar 

  27. Passweg JR, Tiberghien P, Cahn JY, Vowels MR, Camitta BM, Gale RP et al. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia. Bone Marrow Transplant 1998; 21: 153–158.

    Article  CAS  PubMed  Google Scholar 

  28. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg HJ, Stewart P et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66: 664–672.

    CAS  PubMed  Google Scholar 

  29. Hoffmann T, Theobald M, Bunjes D, Weiss M, Heimpel H, Heit W . Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells. Bone Marrow Transplant 1993; 12: 1–8.

    CAS  PubMed  Google Scholar 

  30. Jiang YZ, Kanfer EJ, Macdonald D, Cullis JO, Goldman JM, Barrett AJ . Graft-versus-leukaemia following allogeneic bone marrow transplantation: emergence of cytotoxic T lymphocytes reacting to host leukaemia cells. Bone Marrow Transplant 1991; 8: 253–258.

    CAS  PubMed  Google Scholar 

  31. Faber LM, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH . Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia. J Exp Med 1992; 176: 1283–1289.

    Article  CAS  PubMed  Google Scholar 

  32. Truitt RL, Atasoylu AA . Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow. Bone Marrow Transplant 1991; 8: 51–58.

    CAS  PubMed  Google Scholar 

  33. Glass B, Uharek L, Gassmann W, Focks B, Bolouri H, Loeffler H et al. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Ann Hematol 1992; 64: 255–259.

    Article  CAS  PubMed  Google Scholar 

  34. Jiang YZ, Barrett AJ, Goldman JM, Mavroudis DA . Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 1997; 74: 1–6.

    Article  CAS  PubMed  Google Scholar 

  35. Schroff RW, Gale RP, Fahey JL . Regeneration of T cell subpopulations after bone marrow transplantation: cytomegalovirus infection and lymphoid subset imbalance. J Immunol 1982; 129: 1926–1930.

    CAS  PubMed  Google Scholar 

  36. Azogui O, Kalil J, Andersen E, Guillet J, Fellous M, Gluckman E . Peripheral blood T lymphocytes bearing DR antigen after bone marrow transplantation. Transplantation 1983; 35: 513–515.

    Article  CAS  PubMed  Google Scholar 

  37. Hercend T, Takvorian T, Nowill A, Tantravahi R, Moingeon P, Anderson KC et al. Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation. Blood 1986; 67: 722–728.

    CAS  PubMed  Google Scholar 

  38. Keever CA, Klein J, Leong N, Copelan EA, Avalos BR, Kapoor N et al. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT. Bone Marrow Transplant 1993; 12: 289–295.

    CAS  PubMed  Google Scholar 

  39. Mackinnon S, Hows JM, Goldman JM . Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia. Blood 1990; 76: 2037–2045.

    CAS  PubMed  Google Scholar 

  40. Elfenbein GJ, Anderson PN, Humphrey RL, Mullins GM, Sensenbrenner LL, Wands JR et al. Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis. Transplant Proc 1976; 8: 641–646.

    CAS  PubMed  Google Scholar 

  41. Noel DR, Witherspoon RP, Storb R, Atkinson K, Doney K, Mickelson EM et al. Does graft-versus-host disease influence the tempo of immunologic recovery after allogeneic human marrow transplantation? An observation on 56 long-term survivors. Blood 1978; 51: 1087–1105.

    CAS  PubMed  Google Scholar 

  42. Atkinson K, Hansen JA, Storb R, Goehle S, Goldstein G, Thomas ED . T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 1982; 59: 1292–1298.

    CAS  PubMed  Google Scholar 

  43. Ault KA, Antin JH, Ginsburg D, Orkin SH, Rappeport JM, Keohan ML et al. Phenotype of recovering lymphoid cell populations after marrow transplantation. J Exp Med 1985; 161: 1483–1502.

    Article  CAS  PubMed  Google Scholar 

  44. Niederwieser D, Gastl G, Rumpold H, Marth C, Kraft D, Huber C . Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT). Br J Haematol 1987; 65: 301–305.

    Article  CAS  PubMed  Google Scholar 

  45. Herberman RB, Reynolds CW, Ortaldo JR . Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol 1986; 4: 651–680.

    Article  CAS  PubMed  Google Scholar 

  46. Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 2001; 98: 579–585.

    Article  CAS  PubMed  Google Scholar 

  47. Porrata LF, Inwards DJ, Lacy MQ, Markovic SN . Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation. Bone Marrow Transplant 2001; 28: 673–680.

    Article  CAS  PubMed  Google Scholar 

  48. Adler A, Chervenick PA, Whiteside TL, Lotzova E, Herberman RB . Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients. I. Feasibility of LAK generation in adult patients with active disease and in remission. Blood 1988; 71: 709–716.

    CAS  PubMed  Google Scholar 

  49. Nakano E, Tada Y, Ichikawa Y, Fujioka H, Matsuda M, Takaha M et al. Lysis of autologous tumor cells by peripheral blood lymphocytes treated with interleukin 2 in patients with renal cell carcinoma. J Urol 1987; 137: 641–648.

    Article  CAS  PubMed  Google Scholar 

  50. Soiffer RJ, Murray C, Gonin R, Ritz J . Effect of low-dose interleukin-2 on disease relapse after T-cell-depleted allogeneic bone marrow transplantation. Blood 1994; 84: 964–971.

    CAS  PubMed  Google Scholar 

  51. Meyers JD, Flournoy N, Sanders JE, McGuffin RW, Newton BA, Fisher LD et al. Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation. Ann Intern Med 1987; 107: 809–816.

    Article  CAS  PubMed  Google Scholar 

  52. Einsele H, Ehninger G, Steidle M, Fischer I, Bihler S, Gerneth F et al. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation. Blood 1993; 82: 1672–1678.

    CAS  PubMed  Google Scholar 

  53. Fries BC, Khaira D, Pepe MS, Torok-Storb B . Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients. Exp Hematol 1993; 21: 1387–1392.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Ms Norine E Huneke for her expert assistance with BMT database management.

Author information

Authors and Affiliations

  1. Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA

    S Kumar, D A Gastineau, M A Gertz, D J Inwards, M Q Lacy, A Tefferi & M R Litzow

  2. Division of Radiation Oncology, Mayo Clinic, Rochester, MN, USA

    M G Chen

Authors
  1. S Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M G Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D A Gastineau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M A Gertz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D J Inwards
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Q Lacy
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Tefferi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M R Litzow
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, S., Chen, M., Gastineau, D. et al. Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Leukemia 17, 1865–1870 (2003). https://doi.org/10.1038/sj.leu.2403055

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403055

Keywords

This article is cited by

Search

Advanced search

Quick links